
    
      STUDY PLAN Patients will receive initial mFOLFIRINOX (6 cycles) chemotherapy, followed by
      evaluation of the response to the treatment (imaging and laboratory testing) followed by
      SBRT, followed by mFOLFIRINOX chemotherapy.

      In case of exclusion of disease progression after 10 weeks +/- 2 weeks after completion of
      SBRT, patients will be qualified to surgical treatment to attempt a radical surgical
      treatment.
    
  